Mark Mallon charts post-Ironwood course by taking CEO job at NeoGenomics; GlaxoSmithKline vet Feng Ren joins Insilico as CSO
→ Mark Mallon steps aside at Ironwood on March 12 after close to two years at the helm, and he already has a new change …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
